Spots Global Cancer Trial Database for colon
Every month we try and update this database with for colon cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer Surgery | NCT01416168 | Colorectal Canc... | McCorkle Model ... | 60 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer | NCT01186705 | Colon Cancer Rectal Cancer | MK-2206 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®) | NCT03442738 | Adenoma Detecti... | Endocuff group | 55 Years - | Universitätsklinikum Hamburg-Eppendorf | |
A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer | NCT01744340 | Head and Neck C... Colon Cancer | Head and neck Colon- Closed a... | 18 Years - | Brown University | |
Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | NCT00200200 | Hepatic Metasta... Colon Cancer Rectal Cancer | Bevacizumab HAI... HAI plus system... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®) | NCT03442738 | Adenoma Detecti... | Endocuff group | 55 Years - | Universitätsklinikum Hamburg-Eppendorf | |
Latinos CARES (Colorectal Cancer Awareness, Research, Education and Screening) | NCT03078361 | Colorectal Canc... Colorectal Carc... | Immunochemical ... LATINOS CARES T... Standard Interv... | 50 Years - 70 Years | H. Lee Moffitt Cancer Center and Research Institute | |
Tertiary Prevention by Exercise in Colorectal Cancer Therapy | NCT01991847 | Colorectal Canc... | Physical activi... | 40 Years - 80 Years | Technical University of Munich | |
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver | NCT00766220 | Colon Cancer Colorectal Canc... | SIR-spheres Age... Cetuximab Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer | NCT00177307 | Cancer | Bevacizumab Capecitabine Oxaliplatin | 18 Years - | University of Pittsburgh | |
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | NCT00127036 | Adenocarcinoma Colon Cancer | XELOX XELIRI Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Healthy Eating for Colon Cancer Prevention | NCT00475722 | Colon Cancer | 1 Healthy Eatin... 2 Mediterranean | 21 Years - | University of Michigan | |
Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing | NCT00892593 | Colon Cancer | Fecal Immunoche... Fecal Immunoche... | 18 Years - | Forsyth Medical Center | |
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) | NCT01253161 | Neuroendocrine ... Carcinoid Tumor... | Pasireotide Lon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy | NCT02998736 | Abdominal Cance... | Cialis Influenza vacci... | 18 Years - | Ottawa Hospital Research Institute | |
CT and MRI in Preoperative Colon Cancer Staging | NCT05727007 | Colonic Neoplas... | MRI in colon ca... CT in colon can... | 18 Years - 90 Years | Larissa University Hospital | |
Polyp Prevention Trial | NCT00339625 | Diet Polyps Adenoma | low fat, high f... | 35 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | NCT02967289 | Colon Cancer (H... | Irinotecan Folfox Protocol | 18 Years - 75 Years | UNICANCER | |
Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy | NCT01422993 | Neuropathy Gastrointestina... | 12 Week Exercis... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | NCT02967289 | Colon Cancer (H... | Irinotecan Folfox Protocol | 18 Years - 75 Years | UNICANCER | |
Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer | NCT01791309 | Metastatic Colo... | combination pan... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors | NCT04913285 | Solid Tumor, Ad... Non-small Cell ... Melanoma | KIN-2787 KIN-2787 and bi... | 18 Years - | Pierre Fabre Medicament | |
Simvastatin in Colorectal Surgery | NCT00994903 | Intestinal Neop... Perioperative C... | Simvastatin Placebo | 18 Years - 90 Years | University of Auckland, New Zealand | |
Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF | NCT01367275 | Colorectal Canc... Colorectal Aden... | Brivanib Irinotecan | 18 Years - | M.D. Anderson Cancer Center | |
Phase I Trial of Combination of FOLFIRI and SOM 230 | NCT01434069 | Gastrointestina... | SOM230C LAR FOLFIRI Infusio... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Healthy Eating for Colon Cancer Prevention | NCT00475722 | Colon Cancer | 1 Healthy Eatin... 2 Mediterranean | 21 Years - | University of Michigan | |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies | NCT04678648 | Advanced Malign... RAS Mutation Lung Cancer Colon Cancer Glioblastoma Pancreatic Canc... | RSC-1255 Dose E... RSC-1255 Dose E... | 18 Years - | RasCal Therapeutics, Inc. | |
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors | NCT04577963 | Triple Negative... Endometrial Can... Solid Tumor, Un... Colorectal Canc... | Fruquintinib Tislelizumab | 18 Years - | Hutchmed | |
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer | NCT04322539 | Metastatic Colo... Metastatic Colo... | Fruquintinib Placebo | 18 Years - | Hutchmed | |
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis | NCT04024917 | Peritoneal Carc... Pseudomyxoma Pe... Mesothelioma Pe... | Cardiac coheren... Standard care | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients | NCT00774839 | Colon Cancer | Patient Intervi... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP) | NCT01451008 | Cancer Polyp | Compression ana... | 18 Years - 90 Years | Region Skane | |
Study of Economic Circumstances, Service Utilization, and Service Needs Among Older Colon Cancer Patients | NCT00774839 | Colon Cancer | Patient Intervi... | 65 Years - | Memorial Sloan Kettering Cancer Center | |
Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs) | NCT01253161 | Neuroendocrine ... Carcinoid Tumor... | Pasireotide Lon... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection | NCT02388256 | Colorectal Canc... | acupuncture early recovery ... | 18 Years - 75 Years | Korean Medicine Hospital of Pusan National University | |
A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer | NCT01744340 | Head and Neck C... Colon Cancer | Head and neck Colon- Closed a... | 18 Years - | Brown University | |
Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery | NCT02314871 | Colon Cancer Minimal Residua... | Epidural analge... Piritramide Morphine | 18 Years - | The Institute of Molecular and Translational Medicine, Czech Republic | |
A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer | NCT00483834 | Colorectal Canc... | Bevacizumab Irinotecan Capecitabine | 18 Years - | University Health Network, Toronto | |
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway. | NCT02077777 | Colorectal Canc... | Mesalazine | 18 Years - | SOFAR S.p.A. | |
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer | NCT01312857 | Metastatic Colo... | panitumumab Randomization t... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Healthy Eating for Colon Cancer Prevention | NCT00475722 | Colon Cancer | 1 Healthy Eatin... 2 Mediterranean | 21 Years - | University of Michigan | |
Selective Internal Radiation Therapy (SIRT) in Patients With Unresectable Colorectal Cancer Liver Metastases Who Failed Prior Intraarterial Pump Chemotherapy | NCT00972036 | Colon Cancer Rectal Cancer | SIR-spheres® (S... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
EPO906 Therapy in Patients With Advanced Colorectal Cancer | NCT00035087 | Colorectal Neop... Colonic Neoplas... | epothilone b | 18 Years - 85 Years | Novartis | |
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors | NCT03176485 | Metastatic Canc... Melanoma Colon Cancer Differentiated ... Hepatocellular ... Renal Cell Carc... Metastatic Mela... HCC Metastatic Colo... | Solar Simulator | 18 Years - | University of Arizona | |
Focusing Implementation to Bring Effective Reminders (FIBER) | NCT00656838 | Colorectal Canc... | Patients receiv... | 50 Years - 80 Years | Kaiser Permanente | |
A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors | NCT02605083 | Cancer | eFT508 | 18 Years - | Effector Therapeutics | |
A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome | NCT01286662 | Gardner Syndrom... Colorectal Carc... Desmoid Tumor | - | Triemli Hospital | ||
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer | NCT00444054 | Cancer Breast Cancer Colon Cancer Cervical Cancer Uterine Cancer Ovarian Cancer | Very low carboh... | 21 Years - | Albert Einstein College of Medicine | |
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer | NCT01345175 | Rectal Cancer | Rifaximin Placebo | 21 Years - | Memorial Sloan Kettering Cancer Center | |
A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome | NCT01286662 | Gardner Syndrom... Colorectal Carc... Desmoid Tumor | - | Triemli Hospital | ||
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A) | NCT00127036 | Adenocarcinoma Colon Cancer | XELOX XELIRI Bevacizumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers | NCT03332498 | Colon Cancer Colorectal Canc... Colorectal Carc... Colon Disease | Pembrolizumab Ibrutinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
A Phase I In-Vivo Peptide Applied in the Right Colon | NCT01722058 | Colon Lesions | Peptide applica... | 18 Years - | University of Michigan | |
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors | NCT04577963 | Triple Negative... Endometrial Can... Solid Tumor, Un... Colorectal Canc... | Fruquintinib Tislelizumab | 18 Years - | Hutchmed | |
Evaluation of Microcirculation in Colon Wall and Bowel Anastomosis by Laser Induced Fluorescence Video Angiography | NCT01419860 | Colon Cancer Benign Colon Di... | Elective colon ... | 18 Years - | Ostfold Hospital Trust | |
Colorectal Cancer Awareness, Research, Education and Screening (CARES) | NCT01804179 | Colorectal Canc... | Immunochemical ... Standard Interv... CARES Intervent... Baseline Visit ... Follow-up Quest... | 50 Years - 75 Years | H. Lee Moffitt Cancer Center and Research Institute | |
Clinical and Translational Study of STA-9090 | NCT01111838 | Colon Cancer Rectal Cancer | STA-9090 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Phase 1 and 2 Study of PX-866 and Cetuximab | NCT01252628 | Incurable Metas... Incurable Progr... | PX-866 (SCCHN) Cetuximab (SCCH... PX-866 (CRC) Cetuximab (CRC) | 18 Years - | Seagen Inc. | |
FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer | NCT01206530 | Rectal Cancer Colon Cancer Metastasis Adenocarcinoma | Hydroxychloroqu... Oxaliplatin Leucovorin 5-fluorouracil 5-fluorouracil Bevacizumab | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers | NCT03332498 | Colon Cancer Colorectal Canc... Colorectal Carc... Colon Disease | Pembrolizumab Ibrutinib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Fiber and Fish Oil Supplements for the Prevention of Colorectal Cancer | NCT04211766 | Healthy Subject | Dietary Fiber Fish Oil Comparator Comparator | 50 Years - 75 Years | Fred Hutchinson Cancer Center | |
KRAS Wild-type Metastatic Colorectal Cancer Trial | NCT00879385 | Colorectal Canc... | Dacogen™ (decit... Vectibix® (pani... | 18 Years - | University of Utah | |
Clinical and Translational Study of STA-9090 | NCT01111838 | Colon Cancer Rectal Cancer | STA-9090 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer | NCT00215982 | Colorectal Canc... | capecitabine Oxaliplatin Irinotecan | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery | NCT02314871 | Colon Cancer Minimal Residua... | Epidural analge... Piritramide Morphine | 18 Years - | The Institute of Molecular and Translational Medicine, Czech Republic | |
Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an "in Vivo" Evaluation of the Molecular Effects on β-catenin Signaling Pathway. | NCT02077777 | Colorectal Canc... | Mesalazine | 18 Years - | SOFAR S.p.A. | |
Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy | NCT02998736 | Abdominal Cance... | Cialis Influenza vacci... | 18 Years - | Ottawa Hospital Research Institute | |
Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making | NCT01558583 | Colorectal Canc... Colon Cancer Prostate Cancer | Rating and Rank... Discrete Choice... Balance Sheet T... | 50 Years - 75 Years | University of North Carolina, Chapel Hill | |
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer | NCT00444054 | Cancer Breast Cancer Colon Cancer Cervical Cancer Uterine Cancer Ovarian Cancer | Very low carboh... | 21 Years - | Albert Einstein College of Medicine | |
Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors | NCT02257476 | Neoplasms Malignancies | Carfilzomib Dexamethasone | 18 Years - | Emory University | |
Tertiary Prevention by Exercise in Colorectal Cancer Therapy | NCT01991847 | Colorectal Canc... | Physical activi... | 40 Years - 80 Years | Technical University of Munich | |
Clinical and Translational Study of STA-9090 | NCT01111838 | Colon Cancer Rectal Cancer | STA-9090 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab | NCT01436617 | Colon Cancer Head and Neck C... Allergic Reacti... | blood sample | 18 Years - | Centre Francois Baclesse | |
Laparoscopic Versus Open Right Colectomy for Right Colon Cancer | NCT05713903 | Colon Cancer | Laparoscopic ri... Open right cole... | 18 Years - 90 Years | Larissa University Hospital | |
Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery | NCT00747292 | Neoplasm Diverticular Di... Analgesia | epidural PCA Spinal | 18 Years - | Minimal Access Therapy Training Unit | |
Impact of Bariatric Surgery on the Gut Environment | NCT04345328 | Bariatric Surge... | 18 Years - 80 Years | KU Leuven | ||
Laparoscopic Versus Open Right Colectomy for Right Colon Cancer | NCT05713903 | Colon Cancer | Laparoscopic ri... Open right cole... | 18 Years - 90 Years | Larissa University Hospital | |
Simvastatin in Colorectal Surgery | NCT00994903 | Intestinal Neop... Perioperative C... | Simvastatin Placebo | 18 Years - 90 Years | University of Auckland, New Zealand |